NZ198702A - Antihypertensive compounds containing amide linkage and pharmaceutical compositions - Google Patents
Antihypertensive compounds containing amide linkage and pharmaceutical compositionsInfo
- Publication number
- NZ198702A NZ198702A NZ198702A NZ19870281A NZ198702A NZ 198702 A NZ198702 A NZ 198702A NZ 198702 A NZ198702 A NZ 198702A NZ 19870281 A NZ19870281 A NZ 19870281A NZ 198702 A NZ198702 A NZ 198702A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alanyl
- carboxylic acid
- phenylpropyl
- carboethoxy
- azaspiro
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 11
- 239000002220 antihypertensive agent Substances 0.000 title abstract description 3
- 150000001408 amides Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 293
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 116
- 238000000034 method Methods 0.000 claims abstract description 76
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 63
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 39
- 239000001257 hydrogen Substances 0.000 claims abstract description 37
- 150000003839 salts Chemical class 0.000 claims abstract description 27
- 125000004104 aryloxy group Chemical group 0.000 claims abstract description 26
- 150000001413 amino acids Chemical class 0.000 claims abstract description 23
- 235000001014 amino acid Nutrition 0.000 claims abstract description 20
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 20
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 17
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 17
- 108010016626 Dipeptides Proteins 0.000 claims abstract description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000009833 condensation Methods 0.000 claims abstract description 12
- 230000005494 condensation Effects 0.000 claims abstract description 12
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 12
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 6
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 5
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 5
- 229910052720 vanadium Inorganic materials 0.000 claims abstract description 4
- 229910052727 yttrium Inorganic materials 0.000 claims abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 300
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 138
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 124
- 239000002253 acid Substances 0.000 claims description 117
- 239000000203 mixture Substances 0.000 claims description 107
- -1 aryllower elkoxy Chemical group 0.000 claims description 105
- 239000012141 concentrate Substances 0.000 claims description 97
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 81
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 75
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 59
- 238000003756 stirring Methods 0.000 claims description 56
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 54
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 46
- 239000000243 solution Substances 0.000 claims description 45
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 41
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 40
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 38
- 125000004494 ethyl ester group Chemical group 0.000 claims description 38
- 239000011347 resin Substances 0.000 claims description 37
- 229920005989 resin Polymers 0.000 claims description 37
- 229960003767 alanine Drugs 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000000741 silica gel Substances 0.000 claims description 34
- 229910002027 silica gel Inorganic materials 0.000 claims description 34
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 32
- KUSYIGBGHPOWEL-VIFPVBQESA-N (2s)-2-methylnonanoic acid Chemical compound CCCCCCC[C@H](C)C(O)=O KUSYIGBGHPOWEL-VIFPVBQESA-N 0.000 claims description 27
- 150000004702 methyl esters Chemical class 0.000 claims description 25
- 239000011541 reaction mixture Substances 0.000 claims description 25
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 24
- 239000003921 oil Substances 0.000 claims description 23
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 claims description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 20
- 229960000583 acetic acid Drugs 0.000 claims description 20
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 claims description 20
- 150000002148 esters Chemical class 0.000 claims description 19
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- 125000003282 alkyl amino group Chemical group 0.000 claims description 18
- 229940024606 amino acid Drugs 0.000 claims description 18
- 125000004659 aryl alkyl thio group Chemical group 0.000 claims description 18
- 125000003118 aryl group Chemical group 0.000 claims description 18
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 17
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 17
- 125000001980 alanyl group Chemical group 0.000 claims description 17
- 239000000908 ammonium hydroxide Substances 0.000 claims description 17
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 17
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 claims description 17
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 16
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 16
- 239000007787 solid Substances 0.000 claims description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 229930182821 L-proline Natural products 0.000 claims description 15
- 125000004442 acylamino group Chemical group 0.000 claims description 15
- 239000007864 aqueous solution Substances 0.000 claims description 15
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 14
- 239000012362 glacial acetic acid Substances 0.000 claims description 14
- 239000012044 organic layer Substances 0.000 claims description 14
- WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 claims description 14
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 13
- 125000004414 alkyl thio group Chemical group 0.000 claims description 13
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 13
- 239000012074 organic phase Substances 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 13
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- 239000011734 sodium Substances 0.000 claims description 13
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- 125000005843 halogen group Chemical group 0.000 claims description 12
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 12
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 12
- 239000002808 molecular sieve Substances 0.000 claims description 12
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 12
- 125000001769 aryl amino group Chemical group 0.000 claims description 11
- 125000005110 aryl thio group Chemical group 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 11
- 230000007062 hydrolysis Effects 0.000 claims description 11
- 238000006460 hydrolysis reaction Methods 0.000 claims description 11
- 229910052721 tungsten Inorganic materials 0.000 claims description 11
- 229920002261 Corn starch Polymers 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- 239000012230 colorless oil Substances 0.000 claims description 10
- 239000008120 corn starch Substances 0.000 claims description 10
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 claims description 10
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 10
- TYRGLVWXHJRKMT-QMMMGPOBSA-N n-benzyloxycarbonyl-l-serine-betalactone Chemical compound OC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-QMMMGPOBSA-N 0.000 claims description 10
- 239000008188 pellet Substances 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 9
- 125000001424 substituent group Chemical group 0.000 claims description 9
- 239000005977 Ethylene Substances 0.000 claims description 8
- 206010020772 Hypertension Diseases 0.000 claims description 8
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 8
- 230000002378 acidificating effect Effects 0.000 claims description 8
- 230000029936 alkylation Effects 0.000 claims description 8
- 238000005804 alkylation reaction Methods 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 230000032050 esterification Effects 0.000 claims description 8
- 238000005886 esterification reaction Methods 0.000 claims description 8
- 125000001041 indolyl group Chemical group 0.000 claims description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 239000011593 sulfur Substances 0.000 claims description 8
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 7
- STPXIOGYOLJXMZ-UHFFFAOYSA-N ethyl 2-oxo-4-phenylbutanoate Chemical compound CCOC(=O)C(=O)CCC1=CC=CC=C1 STPXIOGYOLJXMZ-UHFFFAOYSA-N 0.000 claims description 7
- 238000009472 formulation Methods 0.000 claims description 7
- 125000002541 furyl group Chemical group 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 239000008101 lactose Substances 0.000 claims description 7
- PRRCQQGBVXMEKW-YFKPBYRVSA-N (8s)-1,4-dithia-7-azoniaspiro[4.4]nonane-8-carboxylate Chemical compound C1N[C@H](C(=O)O)CC21SCCS2 PRRCQQGBVXMEKW-YFKPBYRVSA-N 0.000 claims description 6
- FQISISIMLFMVEY-DJNXLDHESA-N (8s)-7-[2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]acetyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N1([C@@H](CC2(C1)SCCS2)C(O)=O)C(=O)CNC(C(=O)OCC)CCC1=CC=CC=C1 FQISISIMLFMVEY-DJNXLDHESA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- UOQACRNTVQWTFF-UHFFFAOYSA-N decane-1,10-dithiol Chemical compound SCCCCCCCCCCS UOQACRNTVQWTFF-UHFFFAOYSA-N 0.000 claims description 6
- 125000002883 imidazolyl group Chemical group 0.000 claims description 6
- 229940107700 pyruvic acid Drugs 0.000 claims description 6
- 125000001544 thienyl group Chemical group 0.000 claims description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 5
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- ULGUQTOELKSOAJ-UHFFFAOYSA-N ethyl 2,3,3a,4,5,6,7,7a-octahydro-1h-indole-2-carboxylate Chemical compound C1CCCC2NC(C(=O)OCC)CC21 ULGUQTOELKSOAJ-UHFFFAOYSA-N 0.000 claims description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 5
- 239000005457 ice water Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 229960002429 proline Drugs 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- ZITOPJKFJBLAMM-LURJTMIESA-N (2s)-1-(2-oxopropanoyl)pyrrolidine-2-carboxylic acid Chemical compound CC(=O)C(=O)N1CCC[C@H]1C(O)=O ZITOPJKFJBLAMM-LURJTMIESA-N 0.000 claims description 4
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 claims description 4
- WPWUFUBLGADILS-WDSKDSINSA-N Ala-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WPWUFUBLGADILS-WDSKDSINSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 4
- 229930195722 L-methionine Natural products 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims description 4
- 125000004423 acyloxy group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 claims description 4
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 238000005984 hydrogenation reaction Methods 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 4
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- ZJLMKPKYJBQJNH-UHFFFAOYSA-N propane-1,3-dithiol Chemical compound SCCCS ZJLMKPKYJBQJNH-UHFFFAOYSA-N 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 4
- JKIMNUINHCZQLM-IUCAKERBSA-N (2s)-1-[(2s)-2-aminopropanoyl]azocane-2-carboxylic acid Chemical compound C[C@H](N)C(=O)N1CCCCCC[C@H]1C(O)=O JKIMNUINHCZQLM-IUCAKERBSA-N 0.000 claims description 3
- MWOPNYRIFCCIKC-UUEFVBAFSA-N (8s)-2-thia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound C1N[C@H](C(=O)O)CC11CSCC1 MWOPNYRIFCCIKC-UUEFVBAFSA-N 0.000 claims description 3
- VYMPLPIFKRHAAC-UHFFFAOYSA-N 1,2-ethanedithiol Chemical compound SCCS VYMPLPIFKRHAAC-UHFFFAOYSA-N 0.000 claims description 3
- GSXWVOZWKACRTO-UHFFFAOYSA-N 1-ethyl-2,3,3a,4,5,6,7,7a-octahydroindole Chemical compound C1CCCC2N(CC)CCC21 GSXWVOZWKACRTO-UHFFFAOYSA-N 0.000 claims description 3
- SRXRBNCPSVMKIE-UHFFFAOYSA-N 2-azaspiro[4.4]nonane-3-carboxylic acid Chemical compound C1NC(C(=O)O)CC11CCCC1 SRXRBNCPSVMKIE-UHFFFAOYSA-N 0.000 claims description 3
- TYEYBOSBBBHJIV-UHFFFAOYSA-N 2-oxobutanoic acid Chemical compound CCC(=O)C(O)=O TYEYBOSBBBHJIV-UHFFFAOYSA-N 0.000 claims description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 3
- 239000007868 Raney catalyst Substances 0.000 claims description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 3
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 3
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- YULCQASHDYTPMM-UHFFFAOYSA-N ethyl 2,3,3a,4,6,6a-hexahydro-1h-furo[3,4-b]pyrrole-2-carboxylate Chemical compound C1OCC2NC(C(=O)OCC)CC21 YULCQASHDYTPMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 238000003801 milling Methods 0.000 claims description 3
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 claims description 3
- 125000006239 protecting group Chemical group 0.000 claims description 3
- DOYOPBSXEIZLRE-UHFFFAOYSA-N pyrrole-3-carboxylic acid Natural products OC(=O)C=1C=CNC=1 DOYOPBSXEIZLRE-UHFFFAOYSA-N 0.000 claims description 3
- 239000012312 sodium hydride Substances 0.000 claims description 3
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 3
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims description 3
- ZWUABRPGCONAIA-XRVVJQKQSA-N (2S)-2,3,3a,4,6,6a-hexahydro-1H-furo[3,4-b]pyrrole-2-carboxylic acid Chemical compound N1C2C(C[C@H]1C(=O)O)COC2 ZWUABRPGCONAIA-XRVVJQKQSA-N 0.000 claims description 2
- YZVYEXCSLONNSI-HOCLYGCPSA-N (2s)-1-[(2s)-2-(phenylmethoxycarbonylamino)propanoyl]azocane-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCCCCC1)C(O)=O)C(=O)OCC1=CC=CC=C1 YZVYEXCSLONNSI-HOCLYGCPSA-N 0.000 claims description 2
- RKEYKDXXZCICFZ-AKGZTFGVSA-N (2s)-5-hydroxypiperidine-2-carboxylic acid Chemical compound OC1CC[C@@H](C(O)=O)NC1 RKEYKDXXZCICFZ-AKGZTFGVSA-N 0.000 claims description 2
- ODSNARDHJFFSRH-OCAPTIKFSA-N (3as,7ar)-2,3,3a,4,5,6,7,7a-octahydro-1h-isoindole Chemical compound C1CCC[C@@H]2CNC[C@@H]21 ODSNARDHJFFSRH-OCAPTIKFSA-N 0.000 claims description 2
- WLDMPODMCFGWAA-OLQVQODUSA-N (3as,7ar)-3a,4,5,6,7,7a-hexahydroisoindole-1,3-dione Chemical compound C1CCC[C@@H]2C(=O)NC(=O)[C@@H]21 WLDMPODMCFGWAA-OLQVQODUSA-N 0.000 claims description 2
- SRXRBNCPSVMKIE-ZETCQYMHSA-N (3s)-2-azaspiro[4.4]nonane-3-carboxylic acid Chemical compound C1N[C@H](C(=O)O)CC11CCCC1 SRXRBNCPSVMKIE-ZETCQYMHSA-N 0.000 claims description 2
- ZXMYUPJTDAGGFW-UHFFFAOYSA-N 1-azaspiro[4.4]nonane-2-carboxylic acid Chemical compound N1C(C(=O)O)CCC11CCCC1 ZXMYUPJTDAGGFW-UHFFFAOYSA-N 0.000 claims description 2
- HCUARRIEZVDMPT-UHFFFAOYSA-M 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)[O-])=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-M 0.000 claims description 2
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 claims description 2
- ODSNARDHJFFSRH-UHFFFAOYSA-N 2,3,3a,4,5,6,7,7a-octahydro-1h-isoindole Chemical compound C1CCCC2CNCC21 ODSNARDHJFFSRH-UHFFFAOYSA-N 0.000 claims description 2
- LILXDMFJXYAKMK-UHFFFAOYSA-N 2-bromo-1,1-diethoxyethane Chemical compound CCOC(CBr)OCC LILXDMFJXYAKMK-UHFFFAOYSA-N 0.000 claims description 2
- DRZCPHGVEATLFR-UHFFFAOYSA-N 4,4-diethoxybutanenitrile Chemical compound CCOC(OCC)CCC#N DRZCPHGVEATLFR-UHFFFAOYSA-N 0.000 claims description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 claims description 2
- 239000003810 Jones reagent Substances 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- 244000000231 Sesamum indicum Species 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 150000001299 aldehydes Chemical class 0.000 claims description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 2
- 150000001718 carbodiimides Chemical class 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 2
- PGEVGMOTJUZUKY-MERQFXBCSA-N ethyl (2r)-2-amino-3-benzylsulfanylpropanoate;hydrochloride Chemical compound Cl.CCOC(=O)[C@@H](N)CSCC1=CC=CC=C1 PGEVGMOTJUZUKY-MERQFXBCSA-N 0.000 claims description 2
- WGXQJCFTGHCJJL-UHFFFAOYSA-N ethyl 1,2,3,4,4a,5,6,7,8,8a-decahydroquinoline-2-carboxylate Chemical compound C1CCCC2NC(C(=O)OCC)CCC21 WGXQJCFTGHCJJL-UHFFFAOYSA-N 0.000 claims description 2
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 claims description 2
- 125000004464 hydroxyphenyl group Chemical group 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- BRMYZIKAHFEUFJ-UHFFFAOYSA-L mercury diacetate Chemical compound CC(=O)O[Hg]OC(C)=O BRMYZIKAHFEUFJ-UHFFFAOYSA-L 0.000 claims description 2
- KCUNTYMNJVXYKZ-JTQLQIEISA-N methyl (2s)-2-amino-3-(1h-indol-3-yl)propanoate Chemical compound C1=CC=C2C(C[C@H](N)C(=O)OC)=CNC2=C1 KCUNTYMNJVXYKZ-JTQLQIEISA-N 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 238000005192 partition Methods 0.000 claims description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 238000010626 work up procedure Methods 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims 16
- 239000004480 active ingredient Substances 0.000 claims 8
- 239000008187 granular material Substances 0.000 claims 4
- 229960004592 isopropanol Drugs 0.000 claims 4
- QBRHHUXJSQBAGT-DKTYTTGXSA-N (8s)-7-[2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]acetyl]-2-thia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N1([C@@H](CC2(CSCC2)C1)C(O)=O)C(=O)CNC(C(=O)OCC)CCC1=CC=CC=C1 QBRHHUXJSQBAGT-DKTYTTGXSA-N 0.000 claims 3
- 206010011416 Croup infectious Diseases 0.000 claims 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- 230000003276 anti-hypertensive effect Effects 0.000 claims 3
- 201000010549 croup Diseases 0.000 claims 3
- 238000002347 injection Methods 0.000 claims 3
- 239000007924 injection Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- KEDYTOTWMPBSLG-JGWWNCMTSA-N (2s)-1-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2h-cyclopenta[b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CCCC21)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 KEDYTOTWMPBSLG-JGWWNCMTSA-N 0.000 claims 2
- QPPJXNUAKMKLBS-OTTZHXMRSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2,3,3a,4,6,6a-hexahydrothieno[3,4-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CSCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 QPPJXNUAKMKLBS-OTTZHXMRSA-N 0.000 claims 2
- IFTYGOMODVBUPL-ZBBQRLJZSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,6,7,7a-hexahydro-2h-thiopyrano[4,3-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CSCCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 IFTYGOMODVBUPL-ZBBQRLJZSA-N 0.000 claims 2
- FJNMYQLIYAKZMC-FJSDZJTPSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,4,4a,5,7,7a-hexahydro-2h-furo[3,4-b]pyridine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2COCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 FJNMYQLIYAKZMC-FJSDZJTPSA-N 0.000 claims 2
- BZUUFZKMSQKDNY-GSCOYNGXSA-N (2s)-1-[(2s)-2-[(1-methoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2,3,3a,4,6,6a-hexahydrofuro[3,4-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2COCC21)C(O)=O)C(C(=O)OC)CCC1=CC=CC=C1 BZUUFZKMSQKDNY-GSCOYNGXSA-N 0.000 claims 2
- SRCSNTPZUAEFEI-ZETCQYMHSA-N (2s)-2-(2,2-diethoxyethylamino)propanoic acid Chemical compound CCOC(OCC)CN[C@@H](C)C(O)=O SRCSNTPZUAEFEI-ZETCQYMHSA-N 0.000 claims 2
- SAOSCTYRONNFTC-JTQLQIEISA-N (2s)-2-methyldecanoic acid Chemical compound CCCCCCCC[C@H](C)C(O)=O SAOSCTYRONNFTC-JTQLQIEISA-N 0.000 claims 2
- VHOVPEFSJKDBIQ-AKGZTFGVSA-N (2s)-4-formylpyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CC(C=O)CN1 VHOVPEFSJKDBIQ-AKGZTFGVSA-N 0.000 claims 2
- JELSMELPOHWINJ-SPFPWHRZSA-N (3s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2-azaspiro[4.4]nonane-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(CCCC2)C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 JELSMELPOHWINJ-SPFPWHRZSA-N 0.000 claims 2
- DKAYYGABPVIURT-SPFPWHRZSA-N (5s)-4-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,4-thiazonane-5-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCCCSCC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 DKAYYGABPVIURT-SPFPWHRZSA-N 0.000 claims 2
- OCQKZYKNIDDNDJ-NMBLWERJSA-N (8s)-9-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,4-dithia-9-azaspiro[4.5]decane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2(C1)SCCS2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 OCQKZYKNIDDNDJ-NMBLWERJSA-N 0.000 claims 2
- ILWJAOPQHOZXAN-UHFFFAOYSA-N 1,3-dithianyl Chemical group [CH]1SCCCS1 ILWJAOPQHOZXAN-UHFFFAOYSA-N 0.000 claims 2
- IZNGGFJHSRDFDT-QMMMGPOBSA-N C1CCCC11C[C@H](NCC1)C(=O)O Chemical compound C1CCCC11C[C@H](NCC1)C(=O)O IZNGGFJHSRDFDT-QMMMGPOBSA-N 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- CJUMAFVKTCBCJK-UHFFFAOYSA-N N-benzyloxycarbonylglycine Chemical compound OC(=O)CNC(=O)OCC1=CC=CC=C1 CJUMAFVKTCBCJK-UHFFFAOYSA-N 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- CQYBNXGHMBNGCG-RNJXMRFFSA-N octahydroindole-2-carboxylic acid Chemical compound C1CCC[C@H]2N[C@H](C(=O)O)C[C@@H]21 CQYBNXGHMBNGCG-RNJXMRFFSA-N 0.000 claims 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims 2
- CWJNJELEEDZCTI-SPFPWHRZSA-N (10s)-9-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,5-dioxa-9-azaspiro[5.5]undecane-10-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(CC1)OCCCO2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 CWJNJELEEDZCTI-SPFPWHRZSA-N 0.000 claims 1
- OQTOVBUDULLXHV-SPFPWHRZSA-N (10s)-9-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,5-dithia-9-azaspiro[5.5]undecane-10-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(CC1)SCCCS2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 OQTOVBUDULLXHV-SPFPWHRZSA-N 0.000 claims 1
- LQFCEJMYZZJAQP-ULWHTZQDSA-N (10s)-9-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2-oxa-9-azaspiro[5.5]undecane-10-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(COCCC2)CC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 LQFCEJMYZZJAQP-ULWHTZQDSA-N 0.000 claims 1
- RFYJUEKGELNDTJ-QJQMAANRSA-N (10s)-9-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3-oxa-9-azaspiro[5.5]undecane-10-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(CCOCC2)CC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 RFYJUEKGELNDTJ-QJQMAANRSA-N 0.000 claims 1
- NPPNMYRRPCUPBF-MRVPVSSYSA-N (1S)-2-azaspiro[4.5]decane-1-carboxylic acid Chemical compound [C@@H]1(NCCC12CCCCC2)C(=O)O NPPNMYRRPCUPBF-MRVPVSSYSA-N 0.000 claims 1
- OTQNTOFKEXZTHF-ZBBQRLJZSA-N (1s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,6,7,7a-hexahydro-1h-pyrano[3,4-c]pyrrole-1-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](C2CCOCC2C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 OTQNTOFKEXZTHF-ZBBQRLJZSA-N 0.000 claims 1
- ZNDSVVDQVJWXPU-NHVNWABUSA-N (1s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-8-oxa-2-azaspiro[5.5]undecane-1-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](C2(COCCC2)CCC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 ZNDSVVDQVJWXPU-NHVNWABUSA-N 0.000 claims 1
- VURUNEJGWUBFIP-MNBHBKLXSA-N (1s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-9-oxa-2-azaspiro[5.5]undecane-1-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](C2(CCOCC2)CCC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 VURUNEJGWUBFIP-MNBHBKLXSA-N 0.000 claims 1
- AGTXRFGPDRZBSU-SOLGRHFHSA-N (1s)-3-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,2,3,3a,4,6,7,7a-octahydrothiopyrano[3,4-c]pyrrole-1-carboxylic acid Chemical compound N([C@@H](C)C(=O)C1C2CSCCC2[C@H](N1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 AGTXRFGPDRZBSU-SOLGRHFHSA-N 0.000 claims 1
- YBJMVTZCCQCBHN-FJSDZJTPSA-N (2S)-1-[(2S)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-4-(oxan-2-yl)pyrrolidine-2-carboxylic acid Chemical compound C(=O)(O)C(CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)CC(C1)C1OCCCC1 YBJMVTZCCQCBHN-FJSDZJTPSA-N 0.000 claims 1
- FBBPZZKEOZZRTC-OTTZHXMRSA-N (2S)-1-[(2S)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-4-(oxolan-2-yl)pyrrolidine-2-carboxylic acid Chemical compound C[C@H](NC(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CC(C[C@H]1C(O)=O)C1CCCO1 FBBPZZKEOZZRTC-OTTZHXMRSA-N 0.000 claims 1
- OUFSXRHCTCKMDW-MQFTVXPDSA-N (2S)-1-[(2S)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-4-(oxan-2-yl)pyrrolidine-2-carboxylic acid Chemical compound C(=O)(OCC)C(CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)CC(C1)C1OCCCC1 OUFSXRHCTCKMDW-MQFTVXPDSA-N 0.000 claims 1
- AAWISURHYKTGKD-XWAAWYQISA-N (2S)-1-[(2S)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-4-(oxolan-2-yl)pyrrolidine-2-carboxylic acid Chemical compound C(=O)(OCC)C(CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)CC(C1)C1OCCC1 AAWISURHYKTGKD-XWAAWYQISA-N 0.000 claims 1
- DJEPSSNJZLJYBP-VVXOGMOBSA-N (2S)-1-[2-[(1-carboxy-3-phenylpropyl)amino]acetyl]-4-(oxan-2-yl)pyrrolidine-2-carboxylic acid Chemical compound C(=O)(O)C(CCC1=CC=CC=C1)NCC(=O)N1[C@H](C(=O)O)CC(C1)C1OCCCC1 DJEPSSNJZLJYBP-VVXOGMOBSA-N 0.000 claims 1
- TUYBOIMEBPVOHZ-ACAXCVFMSA-N (2S)-4-(1,3-dioxan-2-yl)-1-[(2S)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC(C1)C1OCCCO1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 TUYBOIMEBPVOHZ-ACAXCVFMSA-N 0.000 claims 1
- BIHHLWSUEXDRTF-RXQRSOPUSA-N (2S)-4-(1,3-dioxolan-2-yl)-1-[(2S)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC(C1)C1OCCO1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 BIHHLWSUEXDRTF-RXQRSOPUSA-N 0.000 claims 1
- YSBGEWDPKVVBTF-RXQRSOPUSA-N (2S)-4-(1,3-dithiolan-2-yl)-1-[(2S)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC(C1)C1SCCS1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 YSBGEWDPKVVBTF-RXQRSOPUSA-N 0.000 claims 1
- YTSYVKPZVVBZQW-HRNJWANLSA-N (2r)-1-[(2s)-2-(phenylmethoxycarbonylamino)propanoyl]-2,3,3a,4,6,6a-hexahydrofuro[3,4-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@H](CC2COCC21)C(O)=O)C(=O)OCC1=CC=CC=C1 YTSYVKPZVVBZQW-HRNJWANLSA-N 0.000 claims 1
- YTSYVKPZVVBZQW-HQSMGLLHSA-N (2s)-1-[(2s)-2-(phenylmethoxycarbonylamino)propanoyl]-2,3,3a,4,6,6a-hexahydrofuro[3,4-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2COCC21)C(O)=O)C(=O)OCC1=CC=CC=C1 YTSYVKPZVVBZQW-HQSMGLLHSA-N 0.000 claims 1
- PACMRGBNUMAUGT-NWJMBBFGSA-N (2s)-1-[(2s)-2-[(1-carboxy-2-phenylethyl)amino]propanoyl]-2,3,3a,4,6,6a-hexahydrofuro[3,4-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2COCC21)C(O)=O)C(C(O)=O)CC1=CC=CC=C1 PACMRGBNUMAUGT-NWJMBBFGSA-N 0.000 claims 1
- HBDXAKVDTKRNCN-JDLVMGNASA-N (2s)-1-[(2s)-2-[(1-carboxy-2-phenylmethoxyethyl)amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)C(C(O)=O)COCC1=CC=CC=C1 HBDXAKVDTKRNCN-JDLVMGNASA-N 0.000 claims 1
- KUYZPVSKVPZRSB-ZBBQRLJZSA-N (2s)-1-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-3,4,4a,5,6,7,8,8a-octahydro-2h-quinoline-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2CCCCC21)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 KUYZPVSKVPZRSB-ZBBQRLJZSA-N 0.000 claims 1
- RMHMFHUUHHBAFR-GSCOYNGXSA-N (2s)-1-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-3,4,4a,5,7,7a-hexahydro-2h-thieno[3,4-b]pyridine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2CSCC21)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 RMHMFHUUHHBAFR-GSCOYNGXSA-N 0.000 claims 1
- WPVBIYSYVRRCBO-SPFPWHRZSA-N (2s)-1-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]azecane-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCCCCCCC1)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 WPVBIYSYVRRCBO-SPFPWHRZSA-N 0.000 claims 1
- PGHXCKQBZHVDNP-NMBLWERJSA-N (2s)-1-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]azonane-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCCCCCC1)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 PGHXCKQBZHVDNP-NMBLWERJSA-N 0.000 claims 1
- IXTKBHQGHSKATI-WNHJAPTLSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-3-phenylmethoxypropan-2-yl)amino]propanoyl]-3,3a,4,5,6,7,8,8a-octahydro-2h-cyclohepta[b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CCCCCC21)C(O)=O)C(C(=O)OCC)COCC1=CC=CC=C1 IXTKBHQGHSKATI-WNHJAPTLSA-N 0.000 claims 1
- PNQLPBNDLYSMGA-GSCOYNGXSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-3-phenylpropan-2-yl)amino]propanoyl]-2,3,3a,4,6,6a-hexahydrofuro[3,4-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2COCC21)C(O)=O)C(C(=O)OCC)CC1=CC=CC=C1 PNQLPBNDLYSMGA-GSCOYNGXSA-N 0.000 claims 1
- DHFHQURKYJFDGJ-OTTZHXMRSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2,3,3a,4,6,6a-hexahydrofuro[3,4-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2COCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 DHFHQURKYJFDGJ-OTTZHXMRSA-N 0.000 claims 1
- HDACQVRGBOVJII-ZBBQRLJZSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2h-cyclopenta[b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CCCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 HDACQVRGBOVJII-ZBBQRLJZSA-N 0.000 claims 1
- CNUOSHSHDCWHCW-FJSDZJTPSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,5,7,7a-hexahydro-2h-pyrano[3,4-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CCOCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 CNUOSHSHDCWHCW-FJSDZJTPSA-N 0.000 claims 1
- ZWLYEPALGWWWHN-ZBBQRLJZSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,6,7,7a-hexahydro-2h-pyrano[4,3-b]pyrrole-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2COCCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 ZWLYEPALGWWWHN-ZBBQRLJZSA-N 0.000 claims 1
- MCVKCKYRBUPDMU-WNHJAPTLSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,4,4a,5,6,7,8,8a-octahydro-2h-quinoline-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2CCCCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 MCVKCKYRBUPDMU-WNHJAPTLSA-N 0.000 claims 1
- LOSAGHGGOQMUDV-FJSDZJTPSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,4,4a,5,7,7a-hexahydro-2h-thieno[3,4-b]pyridine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2CSCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 LOSAGHGGOQMUDV-FJSDZJTPSA-N 0.000 claims 1
- NZXYCGPMZQYNIV-QJQMAANRSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-4,4-bis(ethylsulfanyl)piperidine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC(CC1)(SCC)SCC)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 NZXYCGPMZQYNIV-QJQMAANRSA-N 0.000 claims 1
- VIDIAEZCTIMBRM-FHNOQDHRSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-7-thia-1-azaspiro[4.4]nonane-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1C2(CSCC2)CC[C@H]1C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 VIDIAEZCTIMBRM-FHNOQDHRSA-N 0.000 claims 1
- ZNPFWTMZQIXVMP-ULWHTZQDSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-8-oxa-1-azaspiro[5.5]undecane-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1C2(COCCC2)CCC[C@H]1C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 ZNPFWTMZQIXVMP-ULWHTZQDSA-N 0.000 claims 1
- BORABYFZSSBRHD-SPFPWHRZSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-8-thia-1-azaspiro[4.5]decane-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1C2(CCSCC2)CC[C@H]1C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 BORABYFZSSBRHD-SPFPWHRZSA-N 0.000 claims 1
- VHPDJPVRYUFCOY-JKXNBNTCSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-9-thia-1-azaspiro[4.5]decane-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1C2(CSCCC2)CC[C@H]1C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 VHPDJPVRYUFCOY-JKXNBNTCSA-N 0.000 claims 1
- XPOYQJDBVXPCPP-SPFPWHRZSA-N (2s)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]azocane-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCCCCC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 XPOYQJDBVXPCPP-SPFPWHRZSA-N 0.000 claims 1
- YWLZRTBTGYTBTI-JDLVMGNASA-N (2s)-1-[(2s)-2-[(2-benzylsulfanyl-1-carboxyethyl)amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)C(C(O)=O)CSCC1=CC=CC=C1 YWLZRTBTGYTBTI-JDLVMGNASA-N 0.000 claims 1
- OMKGXKUDYQWNDL-QJQMAANRSA-N (2s)-1-[(2s)-2-[(4-ethoxy-4-oxo-3-phenylbutyl)amino]propanoyl]azonane-2-carboxylic acid Chemical compound O=C([C@H](C)NCCC(C(=O)OCC)C=1C=CC=CC=1)N1CCCCCCC[C@H]1C(O)=O OMKGXKUDYQWNDL-QJQMAANRSA-N 0.000 claims 1
- ZYSVWNOPSXCHHW-XIRDDKMYSA-N (2s)-1-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-3-phenylmethoxypropan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)OCC1=CC=CC=C1 ZYSVWNOPSXCHHW-XIRDDKMYSA-N 0.000 claims 1
- KECMOJNAVLOMGT-YGYNJSFOSA-N (2s)-2-[1,3-dioxan-2-ylmethyl-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]amino]propanoic acid Chemical compound N([C@@H](C)C(=O)N(CC1OCCCO1)[C@@H](C)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 KECMOJNAVLOMGT-YGYNJSFOSA-N 0.000 claims 1
- CIGOMLYAIPPEGN-MZQXSQAVSA-N (2s)-2-[1,3-dioxolan-2-ylmethyl-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]amino]propanoic acid Chemical compound N([C@@H](C)C(=O)N(CC1OCCO1)[C@@H](C)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 CIGOMLYAIPPEGN-MZQXSQAVSA-N 0.000 claims 1
- NENGYTOAJHEGQH-YGYNJSFOSA-N (2s)-2-[1,3-dithian-2-ylmethyl-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]amino]propanoic acid Chemical compound N([C@@H](C)C(=O)N(CC1SCCCS1)[C@@H](C)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 NENGYTOAJHEGQH-YGYNJSFOSA-N 0.000 claims 1
- DPCJXYYHKBNRBG-MZQXSQAVSA-N (2s)-2-[1,3-dithiolan-2-ylmethyl-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]amino]propanoic acid Chemical compound N([C@@H](C)C(=O)N(CC1SCCS1)[C@@H](C)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 DPCJXYYHKBNRBG-MZQXSQAVSA-N 0.000 claims 1
- LWIBANSOJGCEHJ-IJXZTRCJSA-N (2s)-2-[2,2-diethoxyethyl-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]amino]propanoic acid Chemical compound CCOC(OCC)CN([C@@H](C)C(O)=O)C(=O)[C@H](C)NC(C(=O)OCC)CCC1=CC=CC=C1 LWIBANSOJGCEHJ-IJXZTRCJSA-N 0.000 claims 1
- WETFHQYPCMZXAM-BEEJXANESA-N (2s)-2-[[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-(thiolan-2-ylmethyl)amino]propanoic acid Chemical compound N([C@@H](C)C(=O)N(CC1SCCC1)[C@@H](C)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 WETFHQYPCMZXAM-BEEJXANESA-N 0.000 claims 1
- ARPVNMIYTVOVEQ-NMBLWERJSA-N (2s)-2-[[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]amino]-3-(2-methyl-1,3-dithian-2-yl)propanoic acid Chemical compound N([C@@H](C)C(=O)N[C@@H](CC1(C)SCCCS1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 ARPVNMIYTVOVEQ-NMBLWERJSA-N 0.000 claims 1
- XZVIBIOOYKLLSH-NBJLRHFZSA-N (2s)-2-[cyclohexyl-[(2s)-2-[(1-methoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]amino]propanoic acid Chemical compound N([C@@H](C)C(=O)N([C@@H](C)C(O)=O)C1CCCCC1)C(C(=O)OC)CCC1=CC=CC=C1 XZVIBIOOYKLLSH-NBJLRHFZSA-N 0.000 claims 1
- YSEQNZOXHCKLOG-QMMMGPOBSA-N (2s)-2-methyloctanoic acid Chemical compound CCCCCC[C@H](C)C(O)=O YSEQNZOXHCKLOG-QMMMGPOBSA-N 0.000 claims 1
- HWNGLKPRXKKTPK-ONQHYROSSA-N (2s)-3,4-dihydroxypyrrolidine-2-carboxylic acid Chemical compound OC1CN[C@H](C(O)=O)C1O HWNGLKPRXKKTPK-ONQHYROSSA-N 0.000 claims 1
- WYHDGRLNWABGDP-RXQRSOPUSA-N (2s)-4-(dimethoxymethyl)-1-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]pyrrolidine-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC(C1)C(OC)OC)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 WYHDGRLNWABGDP-RXQRSOPUSA-N 0.000 claims 1
- UAGFTQCWTTYZKO-WCCKRBBISA-N (2s)-pyrrolidine-2-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H]1CCCN1 UAGFTQCWTTYZKO-WCCKRBBISA-N 0.000 claims 1
- VGOXYUAJLNRRRS-AVHZRVKJSA-N (3s)-2-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-7-oxa-2-azaspiro[4.5]decane-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(C1)COCCC2)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 VGOXYUAJLNRRRS-AVHZRVKJSA-N 0.000 claims 1
- ZGRSXVVEWMYHOH-QJQMAANRSA-N (3s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2-azaspiro[4.5]decane-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(C1)CCCCC2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 ZGRSXVVEWMYHOH-QJQMAANRSA-N 0.000 claims 1
- CCBPBUDHLFHOAS-LLLPINGXSA-N (3s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2-azaspiro[5.5]undecane-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2(CCCCC2)C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 CCBPBUDHLFHOAS-LLLPINGXSA-N 0.000 claims 1
- NIOKJHABODAVIK-ZBBQRLJZSA-N (3s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,6,7,7a-hexahydro-1h-pyrano[3,4-c]pyrrole-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](C2COCCC2C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 NIOKJHABODAVIK-ZBBQRLJZSA-N 0.000 claims 1
- SGEAGDRMRRRKCB-NMBLWERJSA-N (3s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-6,10-dioxa-2-azaspiro[4.5]decane-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(C1)OCCCO2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 SGEAGDRMRRRKCB-NMBLWERJSA-N 0.000 claims 1
- JOTBUCPVWJSXBV-NMBLWERJSA-N (3s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-6,10-dithia-2-azaspiro[4.5]decane-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(C1)SCCCS2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 JOTBUCPVWJSXBV-NMBLWERJSA-N 0.000 claims 1
- CSCVAUQWBWCMOX-SPFPWHRZSA-N (3s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-8-thia-2-azaspiro[4.5]decane-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(C1)CCSCC2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 CSCVAUQWBWCMOX-SPFPWHRZSA-N 0.000 claims 1
- WPRDGWPRQXBFPO-QJQMAANRSA-N (3s)-2-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-9-oxa-2-azaspiro[5.5]undecane-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2(CCOCC2)C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 WPRDGWPRQXBFPO-QJQMAANRSA-N 0.000 claims 1
- XNDDNVPSHVWKEZ-DDPXNHEPSA-N (3s)-4-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,4-thiazocane-3-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@H](CSCCCC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 XNDDNVPSHVWKEZ-DDPXNHEPSA-N 0.000 claims 1
- XAZYXWARXCGTRD-LLLPINGXSA-N (4s)-3-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3-azaspiro[5.5]undecane-4-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(CCCCC2)CC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 XAZYXWARXCGTRD-LLLPINGXSA-N 0.000 claims 1
- ZGGYDMYMFFZKRC-JGWWNCMTSA-N (4s)-5-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-3,3a,4,6,7,7a-hexahydro-1h-thieno[3,4-c]pyridine-4-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](C2CSCC2CC1)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 ZGGYDMYMFFZKRC-JGWWNCMTSA-N 0.000 claims 1
- FJEXDLFFNGRISB-ZKNZNYJQSA-N (4s)-5-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]pyrrole-4-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](C2COCC2C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 FJEXDLFFNGRISB-ZKNZNYJQSA-N 0.000 claims 1
- QUFDXHDFBQWCOW-SPFPWHRZSA-N (4s)-5-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,5-oxazonane-4-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCOCCCC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 QUFDXHDFBQWCOW-SPFPWHRZSA-N 0.000 claims 1
- GMPSZBNDJUEVMO-ZBBQRLJZSA-N (4s)-5-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,6,7,7a-hexahydro-1h-thieno[3,4-c]pyridine-4-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](C2CSCC2CC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 GMPSZBNDJUEVMO-ZBBQRLJZSA-N 0.000 claims 1
- WYBPGCSALLUBCV-HOCLYGCPSA-N (5s)-4-[(2s)-2-(phenylmethoxycarbonylamino)propanoyl]-1,4-thiazonane-5-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCCCSCC1)C(O)=O)C(=O)OCC1=CC=CC=C1 WYBPGCSALLUBCV-HOCLYGCPSA-N 0.000 claims 1
- FNAAEBGFRZDKPW-NMBLWERJSA-N (5s)-4-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-1,4-oxazecane-5-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCCCCOCC1)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 FNAAEBGFRZDKPW-NMBLWERJSA-N 0.000 claims 1
- TXJRIHKQLZKADN-NMBLWERJSA-N (5s)-4-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,4-oxazocane-5-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCCOCC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 TXJRIHKQLZKADN-NMBLWERJSA-N 0.000 claims 1
- UPNCOKMOJIIBGY-FJSDZJTPSA-N (5s)-4-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,5,6,7,7a-hexahydro-2h-furo[3,2-b]pyridine-5-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2OCCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 UPNCOKMOJIIBGY-FJSDZJTPSA-N 0.000 claims 1
- QZEIYYWNYGYGQS-FJSDZJTPSA-N (5s)-4-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,5,6,7,7a-hexahydro-2h-thieno[3,2-b]pyridine-5-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2SCCC21)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 QZEIYYWNYGYGQS-FJSDZJTPSA-N 0.000 claims 1
- ZUIYCYHOKOSLLL-IUCAKERBSA-N (5s)-4-[(2s)-2-aminopropanoyl]-1,4-thiazonane-5-carboxylic acid Chemical compound C[C@H](N)C(=O)N1CCSCCCC[C@H]1C(O)=O ZUIYCYHOKOSLLL-IUCAKERBSA-N 0.000 claims 1
- QWDLOYYFBSCXNO-FJSDZJTPSA-N (5s)-6-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,5,7,7a-hexahydro-2h-furo[2,3-c]pyridine-5-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CCOC2C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 QWDLOYYFBSCXNO-FJSDZJTPSA-N 0.000 claims 1
- VTSKZCKUPLMYGF-SPFPWHRZSA-N (5s)-6-[(2s)-2-[(1-methoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,6-thiazecane-5-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCCSCCCC1)C(O)=O)C(C(=O)OC)CCC1=CC=CC=C1 VTSKZCKUPLMYGF-SPFPWHRZSA-N 0.000 claims 1
- DUEANXDBMHOEFW-ZBBQRLJZSA-N (6s)-5-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,6,7,7a-hexahydro-1h-furo[3,4-c]pyridine-6-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2COCC2C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 DUEANXDBMHOEFW-ZBBQRLJZSA-N 0.000 claims 1
- FRSCGAKFTFHLHU-ZBBQRLJZSA-N (6s)-5-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-3,3a,4,6,7,7a-hexahydro-1h-thieno[3,4-c]pyridine-6-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CSCC2C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 FRSCGAKFTFHLHU-ZBBQRLJZSA-N 0.000 claims 1
- DGYYJOWZRWLDNN-ZKNZNYJQSA-N (6s)-7-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-1,3,4,4a,5,6,8,8a-octahydropyrano[3,4-c]pyridine-6-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CCOCC2C1)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 DGYYJOWZRWLDNN-ZKNZNYJQSA-N 0.000 claims 1
- ZAJRYOBUCLQLIK-DKKDMOBXSA-N (6s)-7-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,4-dioxa-7-azaspiro[4.4]nonane-6-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](C2(OCCO2)CC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 ZAJRYOBUCLQLIK-DKKDMOBXSA-N 0.000 claims 1
- XYCBWACIUMDNAI-YKOWGRMDSA-N (6s)-7-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-6-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@H](C2(SCCS2)CC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 XYCBWACIUMDNAI-YKOWGRMDSA-N 0.000 claims 1
- TYMZNESRKPFSQX-WJGSZSDCSA-N (7s)-6-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,3,4,4a,5,7,8,8a-octahydrothiopyrano[4,3-c]pyridine-7-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2CSCCC2C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 TYMZNESRKPFSQX-WJGSZSDCSA-N 0.000 claims 1
- MTLUOIASMAGAPX-JKXNBNTCSA-N (7s)-8-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1-oxa-8-azaspiro[4.5]decane-7-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(OCCC2)CC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 MTLUOIASMAGAPX-JKXNBNTCSA-N 0.000 claims 1
- UOBMFQHCVRVMIG-HRWMIKOJSA-N (8S)-7-[(2S)-2-[[4-(4-chlorophenyl)-1-ethoxy-1-oxobutan-2-yl]amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(C1)SCCS2)C(O)=O)C(C(=O)OCC)CCC1=CC=C(Cl)C=C1 UOBMFQHCVRVMIG-HRWMIKOJSA-N 0.000 claims 1
- OZYDFNHNZMMLDH-JQCDREMPSA-N (8s)-3-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-7-azaspiro[4.5]decane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)C1CC2(CC1)CN[C@@H](CC2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 OZYDFNHNZMMLDH-JQCDREMPSA-N 0.000 claims 1
- FMMDBLMCSDRUPA-VFDRBLODSA-N (8s)-7-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(C1)SCCS2)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 FMMDBLMCSDRUPA-VFDRBLODSA-N 0.000 claims 1
- CLCFKVWSQFNBOZ-GGXMVYKUSA-N (8s)-7-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-2-thia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(CSCC2)C1)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 CLCFKVWSQFNBOZ-GGXMVYKUSA-N 0.000 claims 1
- BWDIZLMPBYAHGW-WJGSZSDCSA-N (8s)-7-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,3,4,4a,5,6,8,8a-octahydrothiopyrano[3,4-c]pyridine-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](C2CSCCC2CC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 BWDIZLMPBYAHGW-WJGSZSDCSA-N 0.000 claims 1
- HRWCVUIFMSZDJS-YKOWGRMDSA-N (8s)-7-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(C1)SCCS2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 HRWCVUIFMSZDJS-YKOWGRMDSA-N 0.000 claims 1
- IXOLTUISSICXBZ-FHNOQDHRSA-N (8s)-7-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1-oxa-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(OCCC2)C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 IXOLTUISSICXBZ-FHNOQDHRSA-N 0.000 claims 1
- JZQMYZYHNUBBGW-FHNOQDHRSA-N (8s)-7-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2-thia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(CSCC2)C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 JZQMYZYHNUBBGW-FHNOQDHRSA-N 0.000 claims 1
- FMXZGRBZJXNRFN-YKOWGRMDSA-N (8s)-7-[(2s)-2-[(3-benzylsulfanyl-1-ethoxy-1-oxopropan-2-yl)amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(C1)SCCS2)C(O)=O)C(C(=O)OCC)CSCC1=CC=CC=C1 FMXZGRBZJXNRFN-YKOWGRMDSA-N 0.000 claims 1
- HDVJEBFDBJUXNI-ZDUSSCGKSA-N (8s)-7-[2-(phenylmethoxycarbonylamino)acetyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound C([C@H](N(C1)C(=O)CNC(=O)OCC=2C=CC=CC=2)C(=O)O)C21SCCS2 HDVJEBFDBJUXNI-ZDUSSCGKSA-N 0.000 claims 1
- KKSQMTJMNALLFX-LOACHALJSA-N (8s)-7-[2-[(1-carboxy-3-phenylpropyl)amino]acetyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid Chemical compound N1([C@@H](CC2(C1)SCCS2)C(O)=O)C(=O)CNC(C(=O)O)CCC1=CC=CC=C1 KKSQMTJMNALLFX-LOACHALJSA-N 0.000 claims 1
- FHJYMEFAZOQJLH-NZEUDUFCSA-N (8s)-9-[(2s)-2-[(1-carboxy-3-phenylpropyl)amino]propanoyl]-1,4-dithia-9-azaspiro[4.5]decane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2(C1)SCCS2)C(O)=O)C(C(O)=O)CCC1=CC=CC=C1 FHJYMEFAZOQJLH-NZEUDUFCSA-N 0.000 claims 1
- ADJKKZUIUDDEPY-NMBLWERJSA-N (8s)-9-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1,4-dioxa-9-azaspiro[4.5]decane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2(C1)OCCO2)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 ADJKKZUIUDDEPY-NMBLWERJSA-N 0.000 claims 1
- POBRSLJWJHIWSB-JKXNBNTCSA-N (8s)-9-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2-oxa-9-azaspiro[4.5]decane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2(COCC2)C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 POBRSLJWJHIWSB-JKXNBNTCSA-N 0.000 claims 1
- ORIFFWOQRRQNTI-FHNOQDHRSA-N (8s)-9-[(2s)-2-[(1-methoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2-oxa-9-azaspiro[4.5]decane-8-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2(COCC2)C1)C(O)=O)C(C(=O)OC)CCC1=CC=CC=C1 ORIFFWOQRRQNTI-FHNOQDHRSA-N 0.000 claims 1
- WPXHEZUOPHRGDK-ULWHTZQDSA-N (9s)-8-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-1-oxa-8-azaspiro[5.5]undecane-9-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2(OCCCC2)C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 WPXHEZUOPHRGDK-ULWHTZQDSA-N 0.000 claims 1
- UURZWOFYUPMIBV-ULWHTZQDSA-N (9s)-8-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-2-oxa-8-azaspiro[5.5]undecane-9-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CCC2(COCCC2)C1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 UURZWOFYUPMIBV-ULWHTZQDSA-N 0.000 claims 1
- KMQKVLVPFMFEID-QJQMAANRSA-N (9s)-8-[(2s)-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino]propanoyl]-8-azaspiro[4.5]decane-9-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1[C@@H](CC2(CCCC2)CC1)C(O)=O)C(C(=O)OCC)CCC1=CC=CC=C1 KMQKVLVPFMFEID-QJQMAANRSA-N 0.000 claims 1
- UIOXNNAWANDJCZ-UHFFFAOYSA-N 1,1-dimethoxypropane Chemical compound CCC(OC)OC UIOXNNAWANDJCZ-UHFFFAOYSA-N 0.000 claims 1
- ADKDJHASTPQGEO-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydrocyclopenta[b]pyrrole Chemical compound C1CNC2CCCC21 ADKDJHASTPQGEO-UHFFFAOYSA-N 0.000 claims 1
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 claims 1
- STNNRJFAZZAILC-UHFFFAOYSA-N 1,5-oxazocane-4-carboxylic acid Chemical compound OC(=O)C1CCOCCCN1 STNNRJFAZZAILC-UHFFFAOYSA-N 0.000 claims 1
- REKCOCMOYWUZED-UHFFFAOYSA-N 1-(3,3-dimethoxypropyl)-1-nitrocyclopentane Chemical compound COC(OC)CCC1([N+]([O-])=O)CCCC1 REKCOCMOYWUZED-UHFFFAOYSA-N 0.000 claims 1
- YZVYEXCSLONNSI-LBAUFKAWSA-N 1-[(2s)-2-(phenylmethoxycarbonylamino)propanoyl]azocane-2-carboxylic acid Chemical compound N([C@@H](C)C(=O)N1C(CCCCCC1)C(O)=O)C(=O)OCC1=CC=CC=C1 YZVYEXCSLONNSI-LBAUFKAWSA-N 0.000 claims 1
- UIOORSWZRBWXCD-ZDUSSCGKSA-N 1-o-benzyl 2-o-ethyl (2s)-4-oxopyrrolidine-1,2-dicarboxylate Chemical compound CCOC(=O)[C@@H]1CC(=O)CN1C(=O)OCC1=CC=CC=C1 UIOORSWZRBWXCD-ZDUSSCGKSA-N 0.000 claims 1
- LWIKLSRLLAWMDN-UHFFFAOYSA-N 2-[1-(aminomethyl)cyclopentyl]acetaldehyde Chemical compound O=CCC1(CN)CCCC1 LWIKLSRLLAWMDN-UHFFFAOYSA-N 0.000 claims 1
- PMGSPDVTAKHCLW-UHFFFAOYSA-N 3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[b]pyrrol-2-one Chemical compound C1CCC2NC(=O)CC21 PMGSPDVTAKHCLW-UHFFFAOYSA-N 0.000 claims 1
- PNSAYTGWJPRUTD-UHFFFAOYSA-N 3-(1-nitrocyclopentyl)propanal Chemical compound O=CCCC1([N+](=O)[O-])CCCC1 PNSAYTGWJPRUTD-UHFFFAOYSA-N 0.000 claims 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical class OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 1
- FBMSDTFPGUWSSK-UHFFFAOYSA-N 7-oxa-1-azaspiro[4.4]nonane-2-carboxylic acid Chemical compound N1C(C(=O)O)CCC11COCC1 FBMSDTFPGUWSSK-UHFFFAOYSA-N 0.000 claims 1
- 229920001817 Agar Polymers 0.000 claims 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims 1
- 101100119767 Caenorhabditis elegans fat-4 gene Proteins 0.000 claims 1
- 101100468762 Caenorhabditis elegans ric-3 gene Proteins 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 206010019133 Hangover Diseases 0.000 claims 1
- CWLQUGTUXBXTLF-YFKPBYRVSA-N N-methylproline Chemical compound CN1CCC[C@H]1C(O)=O CWLQUGTUXBXTLF-YFKPBYRVSA-N 0.000 claims 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 1
- 229910000831 Steel Inorganic materials 0.000 claims 1
- 102100029469 WD repeat and HMG-box DNA-binding protein 1 Human genes 0.000 claims 1
- 101710097421 WD repeat and HMG-box DNA-binding protein 1 Proteins 0.000 claims 1
- 150000001241 acetals Chemical class 0.000 claims 1
- 239000008272 agar Substances 0.000 claims 1
- 125000003302 alkenyloxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 239000008346 aqueous phase Substances 0.000 claims 1
- LPHNXQDGAWZOCU-UHFFFAOYSA-N azocane-2-carboxylic acid hydrate Chemical compound O.N1C(CCCCCC1)C(=O)O LPHNXQDGAWZOCU-UHFFFAOYSA-N 0.000 claims 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 claims 1
- 229940005991 chloric acid Drugs 0.000 claims 1
- 239000008121 dextrose Substances 0.000 claims 1
- YSSSPARMOAYJTE-UHFFFAOYSA-N dibenzo-18-crown-6 Chemical compound O1CCOCCOC2=CC=CC=C2OCCOCCOC2=CC=CC=C21 YSSSPARMOAYJTE-UHFFFAOYSA-N 0.000 claims 1
- 229950010030 dl-alanine Drugs 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- HNBBBKUJWYZGKL-PEHGTWAWSA-N ethyl (8s)-2-thia-7-azaspiro[4.4]nonane-8-carboxylate Chemical compound C1N[C@H](C(=O)OCC)CC11CSCC1 HNBBBKUJWYZGKL-PEHGTWAWSA-N 0.000 claims 1
- RVMNHKXJDVRAPE-HNNXBMFYSA-N ethyl (8s)-7-[2-(phenylmethoxycarbonylamino)acetyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylate Chemical compound C([C@H](N(C1)C(=O)CNC(=O)OCC=2C=CC=CC=2)C(=O)OCC)C21SCCS2 RVMNHKXJDVRAPE-HNNXBMFYSA-N 0.000 claims 1
- ZWKOTRNANCDLSE-UHFFFAOYSA-N ethyl 1,2,3,4,4a,5,7,7a-octahydrofuro[3,4-b]pyridine-2-carboxylate Chemical compound N1C(C(=O)OCC)CCC2COCC21 ZWKOTRNANCDLSE-UHFFFAOYSA-N 0.000 claims 1
- SUWTYCOTEIUZTF-UHFFFAOYSA-N ethyl 1,4-thiazonane-5-carboxylate Chemical compound CCOC(=O)C1CCCCSCCN1 SUWTYCOTEIUZTF-UHFFFAOYSA-N 0.000 claims 1
- QQXQAEWRSVZPJM-UHFFFAOYSA-N ethyl 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)OCC)=CC2=C1 QQXQAEWRSVZPJM-UHFFFAOYSA-N 0.000 claims 1
- DKWAALUXJAKCRQ-UHFFFAOYSA-N ethyl 2-oxo-3-phenylbutanoate Chemical compound CCOC(=O)C(=O)C(C)C1=CC=CC=C1 DKWAALUXJAKCRQ-UHFFFAOYSA-N 0.000 claims 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 229940102223 injectable solution Drugs 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- BLWYXBNNBYXPPL-YFKPBYRVSA-N methyl (2s)-pyrrolidine-2-carboxylate Chemical compound COC(=O)[C@@H]1CCCN1 BLWYXBNNBYXPPL-YFKPBYRVSA-N 0.000 claims 1
- IXKUPTBCNCVFCM-VIFPVBQESA-N methyl (4s)-5-(2-oxopropanoyl)-1,5-oxazocane-4-carboxylate Chemical compound COC(=O)[C@@H]1CCOCCCN1C(=O)C(C)=O IXKUPTBCNCVFCM-VIFPVBQESA-N 0.000 claims 1
- LENTWHDOSMHLEE-LURJTMIESA-N methyl (8s)-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylate Chemical compound C1N[C@H](C(=O)OC)CC21SCCS2 LENTWHDOSMHLEE-LURJTMIESA-N 0.000 claims 1
- RQDDIHNPUSEQFX-UHFFFAOYSA-N methyl 2-amino-6-(phenylmethoxycarbonylamino)hexanoate Chemical compound COC(=O)C(N)CCCCNC(=O)OCC1=CC=CC=C1 RQDDIHNPUSEQFX-UHFFFAOYSA-N 0.000 claims 1
- CJSZWOGCKKDSJG-UHFFFAOYSA-N nitrocyclopentane Chemical compound [O-][N+](=O)C1CCCC1 CJSZWOGCKKDSJG-UHFFFAOYSA-N 0.000 claims 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 claims 1
- 125000004344 phenylpropyl group Chemical group 0.000 claims 1
- 229910003446 platinum oxide Inorganic materials 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- NQLVQOSNDJXLKG-UHFFFAOYSA-N prosulfocarb Chemical compound CCCN(CCC)C(=O)SCC1=CC=CC=C1 NQLVQOSNDJXLKG-UHFFFAOYSA-N 0.000 claims 1
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 claims 1
- 235000002020 sage Nutrition 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 238000010898 silica gel chromatography Methods 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 235000010288 sodium nitrite Nutrition 0.000 claims 1
- 229910001220 stainless steel Inorganic materials 0.000 claims 1
- 239000010935 stainless steel Substances 0.000 claims 1
- 239000010959 steel Substances 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 1
- 239000008215 water for injection Substances 0.000 claims 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract description 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract description 3
- 229940030600 antihypertensive agent Drugs 0.000 abstract description 2
- 239000003112 inhibitor Substances 0.000 abstract description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 abstract 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 abstract 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 abstract 1
- 235000008504 concentrate Nutrition 0.000 description 48
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 12
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 8
- 125000004122 cyclic group Chemical group 0.000 description 7
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 5
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- ZCYXXKJEDCHMGH-UHFFFAOYSA-N nonane Chemical compound CCCC[CH]CCCC ZCYXXKJEDCHMGH-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 2
- ZWUABRPGCONAIA-UHFFFAOYSA-N 2,3,3a,4,6,6a-hexahydro-1h-furo[3,4-b]pyrrole-2-carboxylic acid Chemical compound C1OCC2NC(C(=O)O)CC21 ZWUABRPGCONAIA-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- PYRZPBDTPRQYKG-UHFFFAOYSA-N cyclopentene-1-carboxylic acid Chemical compound OC(=O)C1=CCCC1 PYRZPBDTPRQYKG-UHFFFAOYSA-N 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 2
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229940097258 other antihypertensives in atc Drugs 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 125000003003 spiro group Chemical group 0.000 description 2
- PHICBFWUYUCFKS-UHFFFAOYSA-N spiro[4.4]nonane Chemical compound C1CCCC21CCCC2 PHICBFWUYUCFKS-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- APKRDOMMNFBDSG-NSHDSACASA-N (2S)-2-propylnonanoic acid Chemical compound CCCCCCC[C@H](CCC)C(O)=O APKRDOMMNFBDSG-NSHDSACASA-N 0.000 description 1
- CSWOSPBBIQBWBA-IDKOKCKLSA-N (2s)-1-(2,3,3a,4,5,6,7,7a-octahydroindol-1-yl)-2-aminopropan-1-one Chemical compound C1CCCC2N(C(=O)[C@@H](N)C)CCC21 CSWOSPBBIQBWBA-IDKOKCKLSA-N 0.000 description 1
- BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical compound OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 description 1
- YRCGAHTZOXPQPR-JTQLQIEISA-N (2s)-2-ethylnonanoic acid Chemical compound CCCCCCC[C@H](CC)C(O)=O YRCGAHTZOXPQPR-JTQLQIEISA-N 0.000 description 1
- DMUXSGAKEXSNGN-VIFPVBQESA-N (2s)-2-ethyloctanoic acid Chemical compound CCCCCC[C@H](CC)C(O)=O DMUXSGAKEXSNGN-VIFPVBQESA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
- SBUWIPJHZAJVSM-UHFFFAOYSA-N 1,2,3,3a,4,5,6,7,8,8a-decahydrocyclohepta[b]pyrrole Chemical compound C1CCCCC2NCCC21 SBUWIPJHZAJVSM-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- PIINXYKJQGMIOZ-UHFFFAOYSA-N 1,2-dipyridin-2-ylethane-1,2-dione Chemical compound C=1C=CC=NC=1C(=O)C(=O)C1=CC=CC=N1 PIINXYKJQGMIOZ-UHFFFAOYSA-N 0.000 description 1
- 125000004277 1,3-dioxalan-2-yl group Chemical group [H]C1([H])OC([H])(*)OC1([H])[H] 0.000 description 1
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 1
- KWENTBKLBHHLNV-UHFFFAOYSA-N 1-(3,3-dimethoxypropyl)cyclopentan-1-amine Chemical compound COC(OC)CCC1(N)CCCC1 KWENTBKLBHHLNV-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- FJGFHPNQSDXCFC-UHFFFAOYSA-N 1-azaspiro[4.4]nonane Chemical compound C1CCCC21NCCC2 FJGFHPNQSDXCFC-UHFFFAOYSA-N 0.000 description 1
- WIRBNFZZBOUMSY-UHFFFAOYSA-N 1H-thiopyrano[4,3-c]pyridine Chemical compound C1SC=CC=2C=NC=CC=21 WIRBNFZZBOUMSY-UHFFFAOYSA-N 0.000 description 1
- PPKAIMDMNWBOKN-UHFFFAOYSA-N 2-Oxo-4-phenylbutyric acid Chemical compound OC(=O)C(=O)CCC1=CC=CC=C1 PPKAIMDMNWBOKN-UHFFFAOYSA-N 0.000 description 1
- KUSYIGBGHPOWEL-UHFFFAOYSA-N 2-methyl nonaoic acid Chemical compound CCCCCCCC(C)C(O)=O KUSYIGBGHPOWEL-UHFFFAOYSA-N 0.000 description 1
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 1
- IQOZTIKBIHWYQQ-UHFFFAOYSA-N 4h-1,3-oxazine Chemical compound C1C=COC=N1 IQOZTIKBIHWYQQ-UHFFFAOYSA-N 0.000 description 1
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- WFKPMOVNSJXQQE-UHFFFAOYSA-N 8-thia-2-azaspiro[4.5]decane Chemical compound C1NCCC21CCSCC2 WFKPMOVNSJXQQE-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 101100422638 Caenorhabditis elegans syx-4 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 101100386048 Dictyostelium discoideum cyri gene Proteins 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical class C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 101100330203 Mus musculus Cyrib gene Proteins 0.000 description 1
- GDFAOVXKHJXLEI-VKHMYHEASA-N N-methyl-L-alanine Chemical compound C[NH2+][C@@H](C)C([O-])=O GDFAOVXKHJXLEI-VKHMYHEASA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 101150052863 THY1 gene Proteins 0.000 description 1
- 241000750042 Vini Species 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 1
- 229960002576 amiloride Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 125000003460 beta-lactamyl group Chemical group 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- RDXABLXNTVBVML-UHFFFAOYSA-N diethoxyphosphanyl diethyl phosphite Chemical compound CCOP(OCC)OP(OCC)OCC RDXABLXNTVBVML-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 1
- 125000002474 dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- AVOLMBLBETYQHX-UHFFFAOYSA-N etacrynic acid Chemical compound CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl AVOLMBLBETYQHX-UHFFFAOYSA-N 0.000 description 1
- 229960003199 etacrynic acid Drugs 0.000 description 1
- 239000001761 ethyl methyl cellulose Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229960003883 furosemide Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- DMZGURNRYOUAGC-UHFFFAOYSA-N methyl 2-oxo-4-phenylbutanoate Chemical compound COC(=O)C(=O)CCC1=CC=CC=C1 DMZGURNRYOUAGC-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 125000004373 methylthiopropyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- SIOXPEMLGUPBBT-UHFFFAOYSA-M picolinate Chemical compound [O-]C(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-M 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000006894 reductive elimination reaction Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- CTDQAGUNKPRERK-UHFFFAOYSA-N spirodecane Chemical compound C1CCCC21CCCCC2 CTDQAGUNKPRERK-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- GKTQKQTXHNUFSP-UHFFFAOYSA-N thieno[3,4-c]pyrrole-4,6-dione Chemical compound S1C=C2C(=O)NC(=O)C2=C1 GKTQKQTXHNUFSP-UHFFFAOYSA-N 0.000 description 1
- 229960004605 timolol Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19988680A | 1980-10-23 | 1980-10-23 | |
| US25848481A | 1981-04-28 | 1981-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ198702A true NZ198702A (en) | 1985-08-30 |
Family
ID=26895254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ198702A NZ198702A (en) | 1980-10-23 | 1981-10-20 | Antihypertensive compounds containing amide linkage and pharmaceutical compositions |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US4818749A (enExample) |
| EP (1) | EP0050800B2 (enExample) |
| JP (1) | JPH01163197A (enExample) |
| KR (1) | KR880001843B1 (enExample) |
| AT (1) | ATE20469T1 (enExample) |
| AU (1) | AU554362B2 (enExample) |
| CA (1) | CA1341206C (enExample) |
| CY (1) | CY1469A (enExample) |
| DE (2) | DE19575012I2 (enExample) |
| DK (1) | DK161523C (enExample) |
| ES (1) | ES506414A0 (enExample) |
| FI (1) | FI83222C (enExample) |
| GR (1) | GR75059B (enExample) |
| HK (1) | HK36189A (enExample) |
| HU (1) | HU193146B (enExample) |
| IE (1) | IE53802B1 (enExample) |
| IL (1) | IL64085A (enExample) |
| KE (1) | KE3845A (enExample) |
| LU (1) | LU88621I2 (enExample) |
| MA (1) | MA19309A1 (enExample) |
| MY (1) | MY8700683A (enExample) |
| NL (1) | NL940001I2 (enExample) |
| NO (2) | NO164983C (enExample) |
| NZ (1) | NZ198702A (enExample) |
| OA (1) | OA06929A (enExample) |
| PH (1) | PH21916A (enExample) |
| PT (1) | PT73861B (enExample) |
| SG (1) | SG78188G (enExample) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4933361A (en) * | 1981-12-29 | 1990-06-12 | Hoechst Aktiengesellschaft | Derivatives of bicyclic aminoacids agents containing these compounds and their use |
| US4977260A (en) * | 1986-11-21 | 1990-12-11 | Hoechst Aktiengesellschaft | Intermediates for preparing mono-, bi- and tricyclic amino acids |
| US5011940A (en) * | 1987-07-03 | 1991-04-30 | Hoechst Aktiengesellschaft | Process for the preparation of bicyclic amino carboxylic acids, intermediates in this process, and their use |
| US5053519A (en) * | 1981-11-05 | 1991-10-01 | Hoechst Ag | Cis, endo-2-azabicyclo-[3.3.0]-octane-5-carboxylic acids |
| US5055591A (en) * | 1983-09-16 | 1991-10-08 | Hoechst Aktiengesellschaft | Process for the preparation of octahydropenta(b)pyrrole carboxylates |
| US5068351A (en) * | 1983-09-16 | 1991-11-26 | Hoechst Aktiengesellschaft | Process for the preparation of n octahydropenta (6) pyrrole carboxylates |
| US5098910A (en) * | 1986-10-02 | 1992-03-24 | Hoechst Aktiengesellschaft | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| US5175306A (en) * | 1983-01-31 | 1992-12-29 | Hoechst Aktiengesellschaft | Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters |
| US5231080A (en) * | 1985-10-15 | 1993-07-27 | Hoechst Aktiengesellschaft | Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease |
| US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
| US5403856A (en) * | 1984-04-12 | 1995-04-04 | Hoechst Aktiengesellschaft | Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| US5550255A (en) * | 1984-08-28 | 1996-08-27 | Hoechst Aktiengesellschaft | Cis, endo-2-azabicycloalkane-3-carboxylic acid derivatives |
| US5747504A (en) * | 1984-04-12 | 1998-05-05 | Hoechst Aktiengesellschaft | Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
Families Citing this family (131)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595675A (en) * | 1979-09-19 | 1986-06-17 | Hoechst Aktiengesellschaft | Bicyclic α-iminocarboxylic acid compounds having hypotensive activity |
| US4616030A (en) * | 1979-12-07 | 1986-10-07 | Adir | Perhydroindole-2-carboxylic acids as antihypertensives |
| US4616031A (en) * | 1979-12-07 | 1986-10-07 | Adir | Perhydroindole-2-carboxylic acids as antihypertensives |
| US4616029A (en) * | 1979-12-07 | 1986-10-07 | Adir | Perhydromdole-2-carboxylic acids as antihypertensives |
| US4644008A (en) * | 1979-12-07 | 1987-02-17 | Adir | Perhydroindole-2-carboxylic acids as antihypertensives |
| US4508729A (en) * | 1979-12-07 | 1985-04-02 | Adir | Substituted iminodiacids, their preparation and pharmaceutical compositions containing them |
| US4350704A (en) * | 1980-10-06 | 1982-09-21 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids |
| EP0046953B1 (de) * | 1980-08-30 | 1989-12-06 | Hoechst Aktiengesellschaft | Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung |
| EP0050800B2 (en) * | 1980-10-23 | 1995-06-07 | Schering Corporation | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| US4610816A (en) * | 1980-12-18 | 1986-09-09 | Schering Corporation | Substituted dipeptides as inhibitors of enkephalinases |
| US4906615A (en) * | 1980-12-18 | 1990-03-06 | Schering Corporation | Substituted dipeptides as inhibitors of enkephalinases |
| EP0093805B1 (en) * | 1981-02-17 | 1987-05-13 | Warner-Lambert Company | Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters |
| US4496542A (en) * | 1981-03-30 | 1985-01-29 | Usv Pharmaceutical Corporation | N-substituted-amido-amino acids |
| US4766110A (en) * | 1981-08-21 | 1988-08-23 | Ryan James W | Novel complex amido and imido derivatives of carboxyalkyl peptides |
| EP0081094A1 (en) * | 1981-11-12 | 1983-06-15 | Merck & Co. Inc. | Substituted omega-amino-carboxymethyldipeptide antihypertensive agents |
| US4503043A (en) * | 1981-12-07 | 1985-03-05 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-isoindole-1-carboxylic acids |
| ATE25244T1 (de) * | 1981-12-29 | 1987-02-15 | Hoechst Ag | Neue derivate bicyclischer aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung. |
| EP0088350B1 (en) * | 1982-03-08 | 1985-02-20 | Schering Corporation | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| DE3211397A1 (de) * | 1982-03-27 | 1983-11-10 | Hoechst Ag, 6230 Frankfurt | Spiro (4.(3+n))-2-aza-3-carbonsaeure-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung |
| DE3211676A1 (de) * | 1982-03-30 | 1983-10-06 | Hoechst Ag | Neue derivate von cycloalka (c) pyrrol-carbonsaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue cycloalka (c) pyrrol-carbonsaeuren als zwischenstufen und verfahren zu deren herstellung |
| US4555503A (en) * | 1982-05-05 | 1985-11-26 | Merck & Co., Inc. | N2 -(Substituted)carboxymethyl-N6 -(substituted)-lysyl-and αε-aminoalkyl)glycyl amino acid antihypertensive agents |
| US4483850A (en) * | 1982-05-10 | 1984-11-20 | Merck & Co., Inc. | N-Terminal substituted oligopeptide converting enzyme inhibitors |
| DE3218540A1 (de) * | 1982-05-17 | 1983-11-24 | Hoechst Ag, 6230 Frankfurt | Spiro-2-aza-alkan-3-carbonitrile, verfahren zu ihrer herstellung und ihre verwendung |
| DE3376649D1 (en) * | 1982-06-17 | 1988-06-23 | Schering Corp | Substituted dipeptides, methods for their production, pharmaceutical compositions containing them, method for making such pharmaceutical compositions |
| IL69136A0 (en) * | 1982-07-19 | 1983-10-31 | Squibb & Sons Inc | Substituted peptide compounds |
| US4470973A (en) * | 1982-07-19 | 1984-09-11 | E. R. Squibb & Sons, Inc. | Substituted peptide compounds |
| US4500713A (en) * | 1982-09-23 | 1985-02-19 | Usv Pharmaceutical Corporation | Therapeutic dipeptides |
| US4634716A (en) * | 1982-09-30 | 1987-01-06 | Merck & Co., Inc. | Substituted N-carboxymethyl-aminoacylaminoalkanoic acids useful as antihypertensive agents |
| DE3242151A1 (de) * | 1982-11-13 | 1984-05-17 | Hoechst Ag, 6230 Frankfurt | Neue derivate tricyclischer aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung, sowie neue bicyclische aminosaeuren als zwischenstufen und verfahren zu deren herstellung |
| US4499079A (en) * | 1982-11-18 | 1985-02-12 | E. R. Squibb & Sons, Inc. | Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides |
| US4587234A (en) * | 1982-11-18 | 1986-05-06 | E. R. Squibb & Sons, Inc. | Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides |
| US4642315A (en) * | 1982-11-18 | 1987-02-10 | E. R. Squibb & Sons, Inc. | Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides |
| DE3246503A1 (de) * | 1982-12-16 | 1984-06-20 | Hoechst Ag, 6230 Frankfurt | Derivate der cis, endo-2-azabicyclo-(5.3.0)-decan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung |
| US4826812A (en) * | 1982-12-27 | 1989-05-02 | Schering Corporation | Antiglaucoma agent |
| DE3381850D1 (de) * | 1982-12-27 | 1990-10-04 | Schering Corp | Pharmazeutische zusammensetzung. |
| DE3300774A1 (de) * | 1983-01-12 | 1984-07-12 | Hoechst Ag, 6230 Frankfurt | Neue spirocyclische aminosaeuren, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie neue spirocyclische aminosaeuren als zwischenprodukte und verfahren zu deren herstellung |
| DE3302125A1 (de) * | 1983-01-22 | 1984-07-26 | Boehringer Ingelheim KG, 6507 Ingelheim | Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung |
| DE3303344A1 (de) | 1983-02-02 | 1984-08-02 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von n-alkylierten aminosaeuren und deren estern |
| DK156484A (da) * | 1983-03-16 | 1984-09-17 | Usv Pharma Corp | Aminosyrederivater |
| US4596791A (en) * | 1983-03-16 | 1986-06-24 | Usv Pharmaceutical Corp. | Compounds for treating hypertension |
| US4666906A (en) * | 1983-03-16 | 1987-05-19 | Usv Pharmaceutical Corporation | Compounds for treating hypertension |
| GB8311286D0 (en) * | 1983-04-26 | 1983-06-02 | Searle & Co | Carboxyalkyl peptide derivatives |
| US4585758A (en) * | 1983-05-20 | 1986-04-29 | Usv Pharmaceutical Corp. | Angiotensin-converting enzyme inhibitors |
| US4783444A (en) * | 1984-09-17 | 1988-11-08 | Schering Corporation | Antiglaucoma compositions and methods |
| US4584285A (en) * | 1983-06-02 | 1986-04-22 | Schering Corporation | Antihypertensive agents |
| FR2546886B2 (fr) * | 1983-06-06 | 1986-05-16 | Adir | Derives d'acides isoindoledicarboxyliques, leur preparation et compositions pharmaceutiques les contenant |
| DE3322530A1 (de) * | 1983-06-23 | 1985-01-10 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von mono-, bi- und tricyclischen aminosaeuren |
| US4514391A (en) * | 1983-07-21 | 1985-04-30 | E. R. Squibb & Sons, Inc. | Hydroxy substituted peptide compounds |
| US4642355A (en) * | 1984-02-24 | 1987-02-10 | Otsuka Pharmaceutical Factory, Inc. | Proline derivatives |
| US4556652A (en) * | 1984-03-02 | 1985-12-03 | Usv Pharmaceutical Corp. | Antihypertensive spiro-amidoamino compounds |
| US4555508A (en) * | 1984-03-02 | 1985-11-26 | Usv Pharmaceutical Corp. | Antihypertensive spiro-cyclic compounds |
| DE3408923A1 (de) * | 1984-03-12 | 1985-09-26 | Hoechst Ag, 6230 Frankfurt | Carboxyalkyldipeptidderivate, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
| US4558150A (en) * | 1984-04-19 | 1985-12-10 | E. R. Squibb & Sons, Inc. | Intermediates for preparing amino thiol dipeptides |
| US4500518A (en) * | 1984-04-19 | 1985-02-19 | E. R. Squibb & Sons, Inc. | Amino thiol dipeptides |
| AU569789B2 (en) * | 1984-05-03 | 1988-02-18 | Brigham And Women's Hospital | A.c.e. inhibitors to treat renal diseases |
| CA1244041A (en) * | 1984-07-30 | 1988-11-01 | Elijah H. Gold | Process for the preparation of cis, endo- octahydrocyclopenta¬b|pyrrole-2-carboxylate |
| IT1176983B (it) * | 1984-10-16 | 1987-08-26 | Zambon Spa | Dipeptidi ad attivita' farmacologica |
| EP0187037A3 (en) * | 1984-12-21 | 1988-03-23 | Takeda Chemical Industries, Ltd. | Piperidine derivatives, their production and use |
| CS250699B2 (en) * | 1984-12-21 | 1987-05-14 | Pfizer | Method of octahydro-6-azaindole's depetidic derivatives production |
| US4762821A (en) * | 1985-03-22 | 1988-08-09 | Syntex (U.S.A.) Inc. | N',N"-dialkylguanidino dipeptides |
| DE3529960A1 (de) * | 1985-08-22 | 1987-03-05 | Boehringer Ingelheim Kg | Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung |
| GB2182938B (en) * | 1985-11-13 | 1989-11-08 | Otsuka Pharma Co Ltd | Antihypertensive proline peptides |
| JPH0662671B2 (ja) * | 1986-01-17 | 1994-08-17 | 株式会社大塚製薬工場 | プロリン誘導体 |
| DE3610391A1 (de) * | 1986-03-27 | 1987-10-08 | Hoechst Ag | Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen |
| EP0566157A1 (en) | 1986-06-20 | 1993-10-20 | Schering Corporation | Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
| EP0254032A3 (en) | 1986-06-20 | 1990-09-05 | Schering Corporation | Neutral metalloendopeptidase inhibitors in the treatment of hypertension |
| US5948939A (en) * | 1986-09-10 | 1999-09-07 | Syntex (U.S.A.) Inc. | Selective amidination of diamines |
| ES2037723T3 (es) * | 1986-09-10 | 1993-07-01 | Syntex (U.S.A.) Inc. | Amidinacion selectiva de diaminas. |
| DE3641451A1 (de) * | 1986-12-04 | 1988-06-16 | Hoechst Ag | Derivate bicyclischer aminocarbonsaeuren, verfahren und zwischenprodukte zu deren herstellung sowie deren verwendung |
| US5262436A (en) * | 1987-03-27 | 1993-11-16 | Schering Corporation | Acylamino acid antihypertensives in the treatment of congestive heart failure |
| DE3739690A1 (de) * | 1987-11-24 | 1989-06-08 | Hoechst Ag | Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen |
| DE3801587A1 (de) * | 1988-01-21 | 1989-08-03 | Hoechst Ag | Neue aminosaeureglyceride, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
| DE3803225A1 (de) * | 1988-02-04 | 1989-08-17 | Hoechst Ag | Aminosaeureamide mit psychotroper wirkung, verfahren zu ihrer herstellung, sie enthaltende mittel und deren verwendung |
| HU904967D0 (en) * | 1988-04-22 | 1991-01-28 | Hoechst Ag | Process for producing new azabicyclo(3.3.o)octane-3-carboxylic acid-octylesther derivatives |
| DD284030A5 (de) | 1988-11-24 | 1990-10-31 | Hoechst Ag,De | Verfahren zur herstellung von peptiden mit bradykinin-antagonistischer wirkung |
| ZA902661B (en) * | 1989-04-10 | 1991-01-30 | Schering Corp | Mercapto-acyl amino acids |
| AU6880291A (en) * | 1989-11-21 | 1991-06-13 | Schering Corporation | Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
| US5075302A (en) * | 1990-03-09 | 1991-12-24 | Schering Corporation | Mercaptoacyl aminolactam endopeptidase inhibitors |
| US5173506A (en) * | 1990-08-16 | 1992-12-22 | Schering Corporation | N-(mercaptoalkyl)ureas and carbamates |
| US5225401A (en) * | 1991-08-12 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Treatment of congestive heart failure |
| LT3872B (en) | 1993-12-06 | 1996-04-25 | Hoechst Ag | Novel peptides and pharmaceutical compositions containing them |
| US5859031A (en) | 1995-06-07 | 1999-01-12 | Gpi Nil Holdings, Inc. | Small molecule inhibitors of rotamase enzyme activity |
| US20020042377A1 (en) * | 1995-06-07 | 2002-04-11 | Steiner Joseph P. | Rotamase enzyme activity inhibitors |
| US7056935B2 (en) | 1995-06-07 | 2006-06-06 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
| US5801197A (en) * | 1995-10-31 | 1998-09-01 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
| FR2746394B1 (fr) | 1996-03-20 | 1998-05-29 | Roussel Uclaf | Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
| DK0796855T3 (da) | 1996-03-20 | 2002-05-27 | Hoechst Ag | Hæmmere af knogleresorption og vitronectin-receptorantagonister |
| US5786378A (en) * | 1996-09-25 | 1998-07-28 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters |
| US5801187A (en) | 1996-09-25 | 1998-09-01 | Gpi-Nil Holdings, Inc. | Heterocyclic esters and amides |
| US6218424B1 (en) * | 1996-09-25 | 2001-04-17 | Gpi Nil Holdings, Inc. | Heterocyclic ketone and thioester compounds and uses |
| DE19653647A1 (de) | 1996-12-20 | 1998-06-25 | Hoechst Ag | Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung |
| US20010049381A1 (en) | 1997-06-04 | 2001-12-06 | Gpl Nil Holdings, Inc., | Pyrrolidine derivative hair growth compositions and uses |
| US6187796B1 (en) | 1998-06-03 | 2001-02-13 | Gpi Nil Holdings, Inc. | Sulfone hair growth compositions and uses |
| US6271244B1 (en) | 1998-06-03 | 2001-08-07 | Gpi Nil Holdings, Inc. | N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses |
| US5945441A (en) | 1997-06-04 | 1999-08-31 | Gpi Nil Holdings, Inc. | Pyrrolidine carboxylate hair revitalizing agents |
| US6274602B1 (en) * | 1998-06-03 | 2001-08-14 | Gpi Nil Holdings, Inc. | Heterocyclic thioester and ketone hair growth compositions and uses |
| US6187784B1 (en) | 1998-06-03 | 2001-02-13 | Gpi Nil Holdings, Inc. | Pipecolic acid derivative hair growth compositions and uses |
| DE19741235A1 (de) | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE19741873A1 (de) * | 1997-09-23 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| DE19751251A1 (de) | 1997-11-19 | 1999-05-20 | Hoechst Marion Roussel De Gmbh | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate |
| DE19821483A1 (de) | 1998-05-14 | 1999-11-18 | Hoechst Marion Roussel De Gmbh | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| US6172087B1 (en) | 1998-06-03 | 2001-01-09 | Gpi Nil Holding, Inc. | N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses |
| US6429215B1 (en) | 1998-06-03 | 2002-08-06 | Gpi Nil Holdings, Inc. | N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses |
| US6331537B1 (en) | 1998-06-03 | 2001-12-18 | Gpi Nil Holdings, Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
| CA2334204A1 (en) * | 1998-06-03 | 1999-12-09 | Gpi Nil Holdings, Inc. | Heterocyclic ester and amide hair growth compositions and uses |
| US7338976B1 (en) | 1998-08-14 | 2008-03-04 | Gpi Nil Holdings, Inc. | Heterocyclic esters or amides for vision and memory disorders |
| US6337340B1 (en) | 1998-08-14 | 2002-01-08 | Gpi Nil Holdings, Inc. | Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| US6395758B1 (en) | 1998-08-14 | 2002-05-28 | Gpi Nil Holdings, Inc. | Small molecule carbamates or ureas for vision and memory disorders |
| US6333340B1 (en) | 1998-08-14 | 2001-12-25 | Gpi Nil Holdings, Inc. | Small molecule sulfonamides for vision and memory disorders |
| US6335348B1 (en) | 1998-08-14 | 2002-01-01 | Gpi Nil Holdings, Inc. | Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders |
| US6218423B1 (en) | 1998-08-14 | 2001-04-17 | Gpi Nil Holdings, Inc. | Pyrrolidine derivatives for vision and memory disorders |
| US6506788B1 (en) | 1998-08-14 | 2003-01-14 | Gpi Nil Holdings, Inc. | N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| US6399648B1 (en) | 1998-08-14 | 2002-06-04 | Gpi Nil Holdings, Inc. | N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| US6376517B1 (en) | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
| US6384056B1 (en) | 1998-08-14 | 2002-05-07 | Gpi Nil Holdings, Inc. | Heterocyclic thioesters or ketones for vision and memory disorders |
| US6339101B1 (en) | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| US6462072B1 (en) | 1998-09-21 | 2002-10-08 | Gpi Nil Holdings, Inc. | Cyclic ester or amide derivatives |
| AR036187A1 (es) * | 2001-07-24 | 2004-08-18 | Adir | Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario |
| US6407262B1 (en) | 2001-11-21 | 2002-06-18 | Brantford Chemicals Inc. | Process for the preparation of Ramipril |
| AU2003248584A1 (en) * | 2002-03-01 | 2003-09-16 | Warner-Lambert Company Llc | Method of treating osteoarthritis |
| WO2004092132A1 (en) * | 2003-04-15 | 2004-10-28 | Warner-Lambert Company Llc | [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| BRPI0409428A (pt) * | 2003-04-15 | 2006-04-18 | Warner Lambert Co | derivados de prolina bicìclicos [c]-fundidos e a sua utilização para tratar estados artrìticos |
| ZA200704767B (en) * | 2004-11-05 | 2008-08-27 | King Pharmaceuticals Res & Dev | Stabilized individually coated ramipril particles, compositions and methods |
| EP1987828A1 (en) * | 2005-01-06 | 2008-11-05 | IPCA Laboratories Limited | salts of perindopril and their use in the therapy of hypertension |
| GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
| GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
| GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
| JP2011525533A (ja) * | 2008-06-24 | 2011-09-22 | コデクシス, インコーポレイテッド | 実質的に立体異性的に純粋な縮合二環式プロリン化合物の調製のための生体触媒法 |
| EP2814465B1 (en) | 2012-02-17 | 2019-07-03 | Egis Gyógyszergyár Zrt. | Pharmaceutical formulation having improved stability |
| HUP1300496A2 (hu) | 2013-08-16 | 2015-03-02 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Stabil kombinációs gyógyszerkészítmény |
| WO2015033781A1 (ja) | 2013-09-03 | 2015-03-12 | 長瀬産業株式会社 | 二置換アミノ酸残基を含むジペプチド誘導体の製造方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
| FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
| US4508729A (en) * | 1979-12-07 | 1985-04-02 | Adir | Substituted iminodiacids, their preparation and pharmaceutical compositions containing them |
| ZA811493B (en) * | 1980-04-02 | 1982-03-31 | Warner Lambert Co | Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids |
| IE52663B1 (en) * | 1980-04-02 | 1988-01-20 | Warner Lambert Co | Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids |
| US4350704A (en) * | 1980-10-06 | 1982-09-21 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids |
| EP0046953B1 (de) * | 1980-08-30 | 1989-12-06 | Hoechst Aktiengesellschaft | Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung |
| ZA816292B (en) * | 1980-09-17 | 1983-01-26 | Univ Miami | Carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents |
| JPS5793943A (en) * | 1980-10-06 | 1982-06-11 | Merck & Co Inc | Antihypertensive dipeptide derivative |
| FR2492381A1 (fr) * | 1980-10-21 | 1982-04-23 | Science Union & Cie | Nouveaux acides aza bicyclo alcane carboxyliques substitues leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
| EP0050800B2 (en) * | 1980-10-23 | 1995-06-07 | Schering Corporation | Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them |
| DE3226768A1 (de) * | 1981-11-05 | 1983-05-26 | Hoechst Ag, 6230 Frankfurt | Derivate der cis, endo-2-azabicyclo-(3.3.0)-octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung |
| IE55867B1 (en) * | 1981-12-29 | 1991-02-14 | Hoechst Ag | New derivatives of bicyclic aminoacids,processes for their preparation,agents containing these compounds and their use,and new bicyclic aminoacids as intermediates and processes for their preparation |
-
1981
- 1981-10-15 EP EP81108348A patent/EP0050800B2/en not_active Expired - Lifetime
- 1981-10-15 LU LU88621C patent/LU88621I2/fr unknown
- 1981-10-15 DE DE1995175012 patent/DE19575012I2/de active Active
- 1981-10-15 DE DE8181108348T patent/DE3174844D1/de not_active Expired
- 1981-10-15 AT AT81108348T patent/ATE20469T1/de active
- 1981-10-20 DK DK462581A patent/DK161523C/da not_active IP Right Cessation
- 1981-10-20 NZ NZ198702A patent/NZ198702A/en unknown
- 1981-10-20 FI FI813283A patent/FI83222C/sv not_active IP Right Cessation
- 1981-10-20 MA MA19511A patent/MA19309A1/fr unknown
- 1981-10-20 GR GR66307A patent/GR75059B/el unknown
- 1981-10-20 OA OA57524A patent/OA06929A/xx unknown
- 1981-10-20 CA CA000388336A patent/CA1341206C/en not_active Expired - Fee Related
- 1981-10-20 AU AU76614/81A patent/AU554362B2/en not_active Expired
- 1981-10-20 PH PH26366A patent/PH21916A/en unknown
- 1981-10-21 IL IL64085A patent/IL64085A/xx active IP Right Grant
- 1981-10-21 PT PT73861A patent/PT73861B/pt unknown
- 1981-10-21 NO NO813546A patent/NO164983C/no not_active IP Right Cessation
- 1981-10-21 KR KR1019810004008A patent/KR880001843B1/ko not_active Expired
- 1981-10-21 ES ES506414A patent/ES506414A0/es active Granted
- 1981-10-21 IE IE2475/81A patent/IE53802B1/en not_active IP Right Cessation
- 1981-10-22 HU HU813078A patent/HU193146B/hu unknown
-
1987
- 1987-11-04 US US07/117,008 patent/US4818749A/en not_active Expired - Lifetime
- 1987-12-30 MY MY683/87A patent/MY8700683A/xx unknown
-
1988
- 1988-09-28 US US07/250,300 patent/US4831157A/en not_active Expired - Lifetime
- 1988-11-09 JP JP63283542A patent/JPH01163197A/ja active Pending
- 1988-11-18 KE KE3845A patent/KE3845A/xx unknown
- 1988-11-21 SG SG781/88A patent/SG78188G/en unknown
-
1989
- 1989-05-04 HK HK361/89A patent/HK36189A/en not_active IP Right Cessation
- 1989-07-21 CY CY1469A patent/CY1469A/xx unknown
-
1994
- 1994-01-26 NL NL940001C patent/NL940001I2/nl unknown
-
1995
- 1995-09-22 NO NO1995008C patent/NO1995008I1/no unknown
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061722A (en) * | 1981-11-05 | 1991-10-29 | Hoechst Ag | Cis, endo-2-azabicyclo-[3.3.0]-octane-3-carboxylic acids, a process for their preparation, agents containing these compounds and their use |
| US5053519A (en) * | 1981-11-05 | 1991-10-01 | Hoechst Ag | Cis, endo-2-azabicyclo-[3.3.0]-octane-5-carboxylic acids |
| US4933361A (en) * | 1981-12-29 | 1990-06-12 | Hoechst Aktiengesellschaft | Derivatives of bicyclic aminoacids agents containing these compounds and their use |
| US5175306A (en) * | 1983-01-31 | 1992-12-29 | Hoechst Aktiengesellschaft | Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters |
| US5055591A (en) * | 1983-09-16 | 1991-10-08 | Hoechst Aktiengesellschaft | Process for the preparation of octahydropenta(b)pyrrole carboxylates |
| US5068351A (en) * | 1983-09-16 | 1991-11-26 | Hoechst Aktiengesellschaft | Process for the preparation of n octahydropenta (6) pyrrole carboxylates |
| US5403856A (en) * | 1984-04-12 | 1995-04-04 | Hoechst Aktiengesellschaft | Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| US5747504A (en) * | 1984-04-12 | 1998-05-05 | Hoechst Aktiengesellschaft | Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| US5550255A (en) * | 1984-08-28 | 1996-08-27 | Hoechst Aktiengesellschaft | Cis, endo-2-azabicycloalkane-3-carboxylic acid derivatives |
| US5231080A (en) * | 1985-10-15 | 1993-07-27 | Hoechst Aktiengesellschaft | Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease |
| US5231084A (en) * | 1986-03-27 | 1993-07-27 | Hoechst Aktiengesellschaft | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons |
| US5098910A (en) * | 1986-10-02 | 1992-03-24 | Hoechst Aktiengesellschaft | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| US5500434A (en) * | 1986-10-02 | 1996-03-19 | Hoechst Aktiengesellschaft | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| US5721244A (en) * | 1986-10-02 | 1998-02-24 | Hoechst Aktiengesellschaft | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
| US4977260A (en) * | 1986-11-21 | 1990-12-11 | Hoechst Aktiengesellschaft | Intermediates for preparing mono-, bi- and tricyclic amino acids |
| US5011940A (en) * | 1987-07-03 | 1991-04-30 | Hoechst Aktiengesellschaft | Process for the preparation of bicyclic amino carboxylic acids, intermediates in this process, and their use |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ198702A (en) | Antihypertensive compounds containing amide linkage and pharmaceutical compositions | |
| FI68405C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara kaboxialkyldipeptider | |
| US4562202A (en) | N-Acyl hexahydroindole-2-carboxylic acids and anti-hypertensive use thereof | |
| SK75995A3 (en) | Spiropiperidine derivatives, method of their production and pharmaceutical agent containing them | |
| JPH04253995A (ja) | 新規ペプチド化合物 | |
| JP2000515168A (ja) | スピロ環メタロプロテアーゼ阻害剤 | |
| KR930008094B1 (ko) | 안기오텐신 전환효소 억제제의 제조방법 | |
| FI81106C (fi) | Foerfarande foer framstaellning av farmaceutiskt vaerdefulla aminosyraderivat. | |
| AU594969B2 (en) | Amino acid derivatives | |
| US5231080A (en) | Method for the treatment of atherosclerosis, thrombosis, and peripheral vessel disease | |
| AU621278B2 (en) | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfunctions | |
| US5231084A (en) | Compounds having a cognition adjuvant action, agents containing them, and the use thereof for the treatment and prophylaxis of cognitive dysfuncitons | |
| JPH029896A (ja) | 新規アミノ酸グリセリドおよびその製法 | |
| AU615252B2 (en) | Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system | |
| US5114962A (en) | New amino acid esters, a process for their preparation, medicaments containing them, and the use thereof | |
| US5348944A (en) | Carboxyalkyl dipeptides | |
| IE881803L (en) | New tripeptide derivatives having a polycyclic nitrogenous¹structure, process of the preparation thereof and¹pharmaceutical compositions containing them | |
| CZ413891A3 (cs) | Karboxyalkyldipeptidy, způsoby jejich výroby a farmaceutické kompozice, které je obsahují | |
| DE3532035A1 (de) | Neue n-alkylierte tripeptide, verfahren zu ihrer herstellung, sie enthaltende medikamente und deren verwendung | |
| JPH08500593A (ja) | 置換アザスピラン組成物および該組成物を用いる乾癬の治療方法 | |
| MXPA99002068A (en) | Spirocyclic metalloprotease inhibitors |